en
Scientific article
Open access
English

Evidence of survival benefit was often ambiguous in randomized trials of cancer treatments

Published inJournal of Clinical Epidemiology, vol. 127, p. 1-8
Publication date2020
Abstract

The objective of the study is to estimate the proportion of statistically significant survival improvements reported in randomized trials of cancer treatments that are also compatible with a clinically negligible benefit.

Keywords
  • Confidence Intervals
  • Cross-Sectional Studies
  • Data Interpretation, Statistical
  • Humans
  • Neoplasms/drug therapy/mortality/radiotherapy
  • Periodicals as Topic/statistics & numerical data
  • Probability
  • Randomized Controlled Trials as Topic/statistics & numerical data
  • Treatment Outcome
  • Uncertainty
Citation (ISO format)
PERNEGER, Thomas et al. Evidence of survival benefit was often ambiguous in randomized trials of cancer treatments. In: Journal of Clinical Epidemiology, 2020, vol. 127, p. 1–8. doi: 10.1016/j.jclinepi.2020.06.026
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
ISSN of the journal0895-4356
133views
62downloads

Technical informations

Creation05/03/2021 6:55:00 PM
First validation05/03/2021 6:55:00 PM
Update time03/16/2023 12:34:37 AM
Status update03/16/2023 12:34:35 AM
Last indexation02/12/2024 1:26:26 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack